Announcements

MDPI will be attending the 44th Annual Meeting of the European Society for Paediatric Infectious Diseases, which will be held from 1 to 5 June 2026 in Bologna, Italy, and online.

This prestigious meeting will bring together top experts from across Europe and beyond, united in their dedication to advancing the research, treatment, and prevention of infectious diseases in children.

The following MDPI journals will be represented at the conference:

• Pediatric Reports;
• Children;
• Vaccines;
• Journal of Clinical Medicine (JCM);
• International Journal of Translational Medicine (IJTM);
• Infectious Disease Reports;
• Germs;
• Hygiene;
• Diseases;
• Therapeutics;
• Pharmacy;
• Epidemiologia;
• Pathogens;
• TropicalMed;
• BioMed;
• Immuno.

If you are planning to attend the conference, we encourage you to visit our booth and speak with our representatives. We are eager to meet you in person and assist you with any queries that you may have.

For more information about the conference, please visit the official website at https://espidmeeting.org/.

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held its Editor-in-Chief and Section Editors-in-Chief Annual Meeting on 13 April 2026. This significant event was hosted by the Editor-in-Chief, Prof. Dr. Kent Doi, and 17 Section Editors-in-Chief attended. We are grateful for the support of all participants. This meeting focused on the journal’s strategic improvements and challenges. We all look forward to the further and better development of the journal in 2026. We also remain open to receiving suggestions from other members and welcome further communication with the JCM Editorial Office (jcm@mdpi.com) or Deputy Managing Editors (dme-jcm@mdpi.com).

At the beginning of the meeting, we introduced the following key information regarding MDPI and the journal:

• MDPI’s new office set up, awards, the Research Integrity Team and Ethics Committee;
• Journal’s key performance in 2025;
• Submission trends, editorial board structure, geographic distribution of authors and editors, and marketing activities;
• Strategic plans for the upcoming year, including strengthening quality control, optimizing the peer review process, enhancing author experience, and expanding editorial and reviewer capacity.

The following information was covered in the discussion:

• To identify section-level citation metrics and do targeted improvements;
• The research integrity team has already played a positive role, and support for research integrity and ethics remains a key priority;
• Continue to strengthen regional promotion and deepen cooperation with conferences, achieving greater geographical diversity in the distribution of submissions;
• Increase the journal's participation in major conferences. Engagement in high-impact conferences will significantly enhance the journal's visibility and influence, and several conferences and associations have been recommended for future collaboration;
• To monitor the launch of new Special Issues and the citation performance of their published papers.

Attendee list (ordered alphabetically):

• Prof. Dr. Alberto Signore (“Nuclear Medicine & Radiology” Section Editor-in-Chief), University of Rome “Sapienza”, Italy;
• Dr. Carlos Escobar (“Machine Learning and Artificial Intelligence in Clinical Medicine” Section Editor-in-Chief), La Paz University Hospital, Spain;
• Dr. Carlo Finelli (“Hematology” Section Editor-in-Chief), ¹ Italian MDS Foundation (FISIM - ETS), Italy; ² Istituto di Ematologia “Seràgnoli”, Italy;
• Dr. Eng Ooi (“Otolaryngology” Section Editor-in-Chief), ¹ Flinders Medical Centre, Australia, ² Flinders University, Australia;
• Prof. Dr. Eyal Sheiner (“Obstetrics & Gynecology” Section Editor-in-Chief), Soroka University Medical Center, Israel;
• Prof. Dr. Gregory Y. H. Lip (“Cardiology” Section Editor-in-Chief), ¹ University of Liverpool, UK; ² Aalborg University, Denmark;
• Dr. Huiberdina Lena Koek (“Geriatric Medicine” Section Editor-in-Chief), University Medical Center Utrecht, the Netherlands;
• Prof. Dr. Kent Doi (Editor-in-Chief), University of Tokyo, Japan;
• Prof. Dr. Kenji Dohi (“Brain Injury” Section Editor-in-Chief), Showa Medical University, Japan;
• Prof. Dr. Luis Garcia-Marcos (“Clinical Pediatrics” Section Editor-in-Chief), University of Murcia, Spain;
• Prof. Dr. Masahiro Kohzuki (“Clinical Rehabilitation” Section Editor-in-Chief), Yamagata Prefectural University of Health Sciences, Japan;
• Dr. Milo Frattini (“Oncology” Section Editor-in-Chief), Institute of Pathology, Switzerland;
• Prof. Dr. Naama W. Constantini (“Sports Medicine” Section Editor-in-Chief), Hebrew University, Jerusalem, Israel;
• Dr. Nicholas David Clement (“Orthopedics” Section Editor-in-Chief), Royal Infirmary of Edinburgh, UK;
• Dr. Prof. Dr. Robert Flisiak (“Infectious Diseases” Section Editor-in-Chief), Medical University of Białystok, Poland;
• Prof. Dr. Stephane Mouly (“Pharmacology” Section Editor-in-Chief), Université de Paris Cité, France;
• Dr. Stefanos Bonovas (“Clinical Research Methods” Section Editor-in-Chief), ^1. Humanitas University, Italy; ^2. IRCCS Humanitas Research Hospital, Italy;
• Dr. Sukhwinder Singh Sohal (“Respiratory Medicine” Section Editor-in-Chief), ¹ RMIT University, Australia; ² University of Tasmania, Australia.

Conference: European Hematology Association 2026 Congress
Date: 11–14 June 2026
Location: Stockholm, Sweden

We are pleased to announce that MDPI will be featured in the upcoming European Hematology Association 2026 Congress (EHA 2026). The EHA 2026 is organized by the European Hematology Association, intended for the global hematology community to share the latest clinical and research updates in the subject of hematology. The conference brings together hematologists, researchers, and healthcare professionals to discuss advancements in blood disorders and treatments.

Topics include, but are not limited to, the following:

• Advancing innovation and scientific discovery across basic, translational, and clinical hematology;
• Enhancing diagnostics, treatment strategies, and evidence-based hematology practice;
• Strengthening collaboration, education, patient communication, and professional development within the hematology community.

The following MDPI journals will be represented:

• Thalassemia Reports;
• Hematology Reports;
• Hemato;
• Transplantology;
• Journal of Clinical Medicine (JCM);
• Journal of Cardiovascular Development and Disease (JCDD);
• Medicina;
• Current Oncology;
• Lymphatics;
• Clinics and Practice;
• Cancers;
• Children;
• Neurology International;
• Surgical Techniques Development;
• Therapeutics.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth H2.04 and answering any questions that you may have. For more information about the conference, please visit the following website: https://ehaweb.org/connect-network/eha2026-congress.

As a highly prevalent metabolic disorder, obesity is not merely a physical abnormality; it harbors a range of underlying complications that pose a serious threat to human health. Exploring the underlying mechanisms linking obesity to its associated complications, as well as developing preventive strategies and clinical interventions, remains a key area of research in the medical field today. The Journal of Clinical Medicine (JCM, ISSN: 2077-0383), an open access journal, is pleased to share our recent highly cited papers on obesity. We hope these papers provide useful insights for researchers in selecting treatment options and developing health management strategies. Moreover, several hot topic Special Issues focusing on obesity research are currently open for submission.

1. “Complete Blood Count (CBC)-Derived Inflammation Indexes Are Useful in Predicting Metabolic Syndrome in Adults with Severe Obesity”
by Alice Marra, Adele Bondesan, Diana Caroli and Alessandro Sartorio
J. Clin. Med. 2024, 13(5), 1353; https://doi.org/10.3390/jcm13051353
Full text available online: https://www.mdpi.com/2077-0383/13/5/1353

2. “The Lipid Accumulation Product Index (LAP) and the Cardiometabolic Index (CMI) Are Useful for Predicting the Presence and Severity of Metabolic Syndrome in Adult Patients with Obesity”
by Sofia Tamini, Adele Bondesan, Diana Caroli and Alessandro Sartorio
J. Clin. Med. 2024, 13(10), 2843; https://doi.org/10.3390/jcm13102843
Full text available online: https://www.mdpi.com/2077-0383/13/10/2843

3. “Beyond the Cold: Activating Brown Adipose Tissue as an Approach to Combat Obesity”
by Cristina Elena Negroiu, Iulia Tudorașcu, Cristina Maria Bezna, Sanziana Godeanu, Marina Diaconu, Raluca Danoiu and Suzana Danoiu
J. Clin. Med. 2024, 13(7), 1973; https://doi.org/10.3390/jcm13071973
Full text available online: https://www.mdpi.com/2077-0383/13/7/1973

4. “The Relationship between Resting Metabolic Rate and Body Composition in People Living with Overweight and Obesity”
by Evdoxia Gitsi, Alexander Kokkinos, Sofia K. Konstantinidou, Sarantis Livadas and Georgia Argyrakopoulou
J. Clin. Med. 2024, 13(19), 5862; https://doi.org/10.3390/jcm13195862
Full text available online: https://www.mdpi.com/2077-0383/13/19/5862

5. “Weight Loss Following Bariatric Surgery in People with or without Metabolic Syndrome: A 5-Year Observational Comparative Study”
by Sharanniyan Ragavan, Omar Elhelw, Waseem Majeed, Bilal Alkhaffaf, Siba Senapati, Basil J. Ammori, Rajshekhar N. Mudaliar and Akheel A. Syed
J. Clin. Med. 2024, 13(1), 256; https://doi.org/10.3390/jcm13010256
Full text available online: https://www.mdpi.com/2077-0383/13/1/256

6. “Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects”
by Maurizio De Luca, Amanda Belluzzi, Paulina Salminen, Marco Bueter, Juan Pujol-Rafols, Nasser Sakran, Christine Stier, Halit Eren Taskin, Sonja Chiappetta, Francesco Maria Carrano et al.
J. Clin. Med. 2024, 13(17), 5106; https://doi.org/10.3390/jcm13175106
Full text available online: https://www.mdpi.com/2077-0383/13/17/5106

7. “The Effectiveness of Bariatric Surgery on Treating Infertility in Women—A Systematic Review and Meta-Analysis”
by Hadeel Almutairi, Mohammad Sulaiman Aldhalea, Muhammad Abdulghani Almaaz, Sama Abdalaziz Aljuhani, Rena Ibrahim Aloraini, Abdulrahman Abdullah Alamoudi, Wajd Fahad Alkhalifah, Leen Ahmed Alrushaid, Haneen Wadi Alanzy, Meshal Alzuwayyid et al.
J. Clin. Med. 2024, 13(18), 5569; https://doi.org/10.3390/jcm13185569
Full text available online: https://www.mdpi.com/2077-0383/13/18/5569

8. “Sarcopenia Prevalence among Hospitalized Patients with Severe Obesity: An Observational Study”
by Raffaella Cancello, Ettore Brenna, Davide Soranna, Antonella Zambon, Valentina Villa, Gianluca Castelnuovo, Lorenzo Maria Donini, Luca Busetto, Paolo Capodaglio and Amelia Brunani  
J. Clin. Med. 2024, 13(10), 2880; https://doi.org/10.3390/jcm13102880
Full text available online: https://www.mdpi.com/2077-0383/13/10/2880

9. “Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis”
by Georgiana-Diana Cazac-Panaite, Cristina-Mihaela Lăcătușu, Elena-Daniela Grigorescu, Adina-Bianca Foșălău, Alina Onofriescu and Bogdan-Mircea Mihai
J. Clin. Med. 2025, 14(4), 1042; https://doi.org/10.3390/jcm14041042
Full text available online: https://www.mdpi.com/2077-0383/14/4/1042

10. “The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity”
by Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi and Alessandro Sartorio
J. Clin. Med. 2025, 14(7), 2341; https://doi.org/10.3390/jcm14072341
Full text available online: https://www.mdpi.com/2077-0383/14/7/2341

11. “The Effectiveness of High-Intensity Interval Training vs. Cardio Training for Weight Loss in Patients with Obesity: A Systematic Review”
by Sławomir Jagsz and Marcin Sikora
J. Clin. Med. 2025, 14(4), 1282; https://doi.org/10.3390/jcm14041282
Full text available online: https://www.mdpi.com/2077-0383/14/4/1282

12. “The Role of Gut Microbiota in the Development and Treatment of Obesity and Overweight: A Literature Review”
by Gabriela Augustynowicz, Maria Lasocka, Hubert Paweł Szyller, Marta Dziedziak, Agata Mytych, Joanna Braksator and Tomasz Pytrus
J. Clin. Med. 2025, 14(14), 4933; https://doi.org/10.3390/jcm14144933
Full text available online: https://www.mdpi.com/2077-0383/14/14/4933

13. “Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?”
by Lara Mari, Stefano Lazzer, Alessandro Gatti, Mattia D’Alleva, Simone Zaccaron, Jacopo Stafuzza, Enrico Rejc, Matteo Vandoni, Adele Bondesan, Diana Caroli et al.
J. Clin. Med. 2025, 14(6), 2085; https://doi.org/10.3390/jcm14062085
Full text available online: https://www.mdpi.com/2077-0383/14/6/2085

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the “Hematology” Section across two sessions on 30 March and 8 April 2026. We greatly appreciate the Section Editor-in-Chief, Dr. Carlo Finelli, for hosting these two meetings, which were attended by 21 Editorial Board Members in total. We thank the members for their strong support. We have gotten many more suggestions and hope to work together to boost the journal and Section’s development. We also welcome members who are unable to attend the meetings to share their suggestions and ideas with the JCM Editorial Office (jcm@mdpi.com) or Deputy Managing Editors (dme-jcm@mdpi.com) at any time. We are glad to invite you to review this event.

The meeting started with a presentation about the development of the journal, as well as the Section “Hematology” in particular and the following information was presented:

• JCM’s 2025 performance data, distribution of authors and Editorial Board Members, editorial procedure details, and paper promotion channels;
• JCM’s diverse marketing activities, including conference sponsorship, free online webinars, virtual conferences (IOCCM 2026), social media accounts, awards, society collaborations, and academic publishing workshop;
• Basic data of the “Hematology” Section, including the most popular publications and Special Issues within recent two years, the most active member, and an overview of the Section Members.

The following topics were discussed at the Editorial Board meetings:

• Refining the journal’s strategic direction and defining its target audience more precisely;
• Expanding the Editorial Board to include more new members. A larger and more geographically diverse membership would enhance the journal’s visibility and encourage more submissions;
• Taking measures to increase the journal’s impact factor, such as inviting well-established researchers to contribute papers on trending topics, which could significantly improve citation performance;
• Emphasizing the importance of interdisciplinary content and emerging fields of artificial intelligence;
• Focusing on attracting young researchers, prioritizing their needs and expectations, developing periodic development strategies, building distinctive features, and boosting appeal through differentiated content and supporting services;
• Members who expressed interest in our Academic Publishing Workshops and had positive suggestions;
• A member who participated in the management of Special Issue also shared his experience;
• Strengthening the support and guidance for young researchers who have difficulties in the publishing process. We hope to provide a more supportive, easy-to-use platform and to welcome young researchers’ long-term participation.

Attendee list (ordered alphabetically):

• Prof. Dr. Alicia Rovo, University of Bern, Switzerland;
• Prof. Dr. Andrea Gallamini, Antoine Lacassagne Cancer Center, France;
• Dr. Angelo Claudio Molinari, Giannina Gaslini Scientific Institute, Italy;
• Prof. Dr. Argiris S. Symeonidis, University of Patras, Greece;
• Prof. Dr. Bernhard Lämmle, ¹ University of Bern, Switzerland; ² Johannes Gutenberg University, Germany; ³ University College London, UK;
• Dr. Carlo Finelli (Section Editor-in-Chief), ¹ Italian MDS Foundation (FISIM - ETS), Italy; ² Istituto di Ematologia “Seràgnoli”, Italy;
• Prof. Dr. Fenella Jane Kirkham, UCL Great Ormond Street Institute of Child Health, UK;
• Prof. Dr. Frederic Garban, University Hospital of Grenoble Alpes France, France; Grenoble Alpes University, France;
• Dr. Giuseppe Milone, Azienda Ospedaliero Universitaria “Policlinico G. Rodolico—San Marco”, Italy;
• Dr. Hideo Wada, Mie Prefectural General Medical Center, Japan;
• Prof. Dr. Håkon Reikvam, Haukeland University Hospital, Norway;
• Dr. Ioannis Ntanasis-Stathopoulos, National and Kapodistrian University of Athens, Greece;
• Prof. Dr. Jasmine M. Zain, Memorial Sloan Kettering Cancer Center, New York, USA;
• Prof. Marc Vasse, Hospital Foch, France; Université Paris-Saclay, France;
• Prof. Dr. Moshe Mittelman, Tel Aviv University, Israel;
• Dr. Pellegrino Musto, ¹ IRCCS-CROB, Referral Cancer Center of Basilicata, Italy; ² University of Bari Medical School, Italy;
• Dr. Pilar Solves, Hospital Universitari i Politècnica La Fe, Spain;
• Dr. Raymond Siu Ming Wong, The Chinese University of Hong Kong, China;
• Prof. Dr. Simone Cesaro, Azienda Ospedaliera Universitaria Integrata, Italy;
• Prof. Dr. Swaminathan P. Iyer, The University of Texas MD Anderson Cancer Center, USA;
• Prof. Dr. Tadeusz Robak, Medical University of Lodz, Poland;
• Dr. Vincent Ribrag, Gustave Roussy, France.

To access additional statistics for the “Hematology” Section, please click here.

As part of its continued efforts to support impactful cancer research and foster scientific dialogue, MDPI is spotlighting head and neck cancer in this edition. Encompassing a diverse group of malignancies affecting the oral cavity, pharynx, and larynx, head and neck cancers collectively account for over 900,000 new cases and more than 400,000 deaths globally each year.

In recent years, shifting epidemiological patterns, particularly the rise of HPV-associated cancers, have introduced new challenges and opportunities in both research and clinical practice. These developments call for deeper insights into disease mechanisms, as well as more precise approaches to diagnosis, treatment, and patient stratification.

By bringing together cutting-edge research, focused Special Issues, and an expert-led webinar, MDPI journals aim to continue to facilitate knowledge exchange and highlight emerging advances in the field. These efforts play an important role in advancing innovation, improving early detection and therapeutic strategies, and ultimately enhancing outcomes for patients worldwide.

Keynote speakers
Dr. Kousik Kumar Kesh, St. Louis University, USA	Prof. Dr. Richard Yuxiong Su, The University of Hong Kong, Hong Kong S.A.R	Dr. Jennifer Anderson, The University of Texas, USA
Dr. Jay J. Liao, University of Washington Medical Center, USA	Prof. Dr. Wendell G. Yarbrough, University of North Carolina, USA	Dr. Joshua D. Smith, University of Pittsburgh Medical Center, USA

Register for this webinar for free here!

“Enhancing Patient Outcomes in Head and Neck Cancer Radiotherapy: Integration of Electronic Patient-Reported Outcomes and Artificial Intelligence-Driven Oncology Care Using Large Language Models”
by ChihYing Liao, ChinNan Chu, TingChun Lin, TzuYao Chou and MengHsiun Tsai
Cancers 2025, 17(14), 2345; https://doi.org/10.3390/cancers17142345

“Advancing Head and Neck Cancer Therapies: From Conventional Treatments to Emerging Strategies”
by Aleksandra Mordzińska-Rak, Ilona Telejko, Grzegorz Adamczuk, Tomasz Trombik, Andrzej Stepulak and Ewa Błaszczak
Biomedicines 2025, 13(5), 1046; https://doi.org/10.3390/biomedicines13051046

“The Role of Dysphagia on Head and Neck Cancer Patients’ Quality of Life, Functional Disabilities and Psychological Distress: Outcomes of Cancer Rehabilitation from an Observational Single-Center Study”
by Špela Matko, Christina Knauseder, David Riedl, Vincent Grote, Michael J. Fischer, Samuel Moritz Vorbach, Karin Pfaller-Frank, Wilhelm Frank and Thomas Licht
Curr. Oncol. 2025, 32(4), 220; https://doi.org/10.3390/curroncol32040220

“PDLIM3 Regulates Migration and Invasion of Head and Neck Squamous Cell Carcinoma via YAP–Mediated Epithelial–Mesenchymal Transition”
by Fan Yang, Ying Zhou, You Zhang, Weideng Wei, Fei Huang, Dan Yang, Yixin Zhang, Ruiyang Zhang, Xiaoqiang Xia, Qianming Chen et al.
Int. J. Mol. Sci. 2025, 26(7), 3147; https://doi.org/10.3390/ijms26073147

“Inflammatory Biomarkers and Oral Health Disorders as Predictors of Head and Neck Cancer: A Retrospective Longitudinal Study”
by Amr Sayed Ghanem, Kitti Sipos, Ágnes Tóth and Attila Csaba Nagy
Int. J. Mol. Sci. 2025, 26(5), 2279; https://doi.org/10.3390/ijms26052279

“Trends in Incidence and Mortality of Head and Neck Cancer Subsites Among Elderly Patients: A Population-Based Analysis”
by Małgorzata Wierzbicka, Wioletta Pietruszewska, Adam Maciejczyk and Jarosław Markowski
Cancers 2025, 17(3), 548; https://doi.org/10.3390/cancers17030548

“Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons”
by William T. Barham, Marshall Patrick Stagg, Rula Mualla, Michael DiLeo and Sagar Kansara
Cancers 2025, 17(1), 144; https://doi.org/10.3390/cancers17010144

“Identification of Biomarkers for Diagnosis and Prognosis of Head and Neck Cancer: Bioinformatics Approach”
by Alexandra Fernandes and Rui Vitorino
Targets 2024, 2(4), 470-480; https://doi.org/10.3390/targets2040026

“Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers”
by Riccardo Gili, Simone Caprioli, Paola Lovino Camerino, Gianluca Sacco, Tommaso Ruelle, Daria Maria Filippini, Silvia Pamparino, Stefania Vecchio, Filippo Marchi, Lucia Del Mastro et al.
Onco 2024, 4(4), 275-286; https://doi.org/10.3390/onco4040020

“Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions”
by Tuan D. Pham, Muy-Teck Teh, Domniki Chatzopoulou, Simon Holmes and Paul Coulthard
Curr. Oncol. 2024, 31(9), 5255-5290; https://doi.org/10.3390/curroncol31090389

“The Advances in Proton Therapy in Head-and-Neck Cancers” Guest Editors: Dr. Nancy Lee and Dr. Edward Christopher Dee Deadline for manuscript submissions: 31 May 2026	“Decoding and Remodeling the Suppressive Tumor Immune Microenvironment in Head and Neck Cancer” Guest Editors: Dr. Andrew G. Sikora and Dr. Jennifer L. Anderson Deadline for manuscript submissions: 20 June 2026
“The Role of Targeted Therapy in Head and Neck Cancers” Guest Editor: Dr. Rikki A.M. Brown Deadline for manuscript submissions: 30 June 2026	“Molecular Targets for HPV-Related Head and Neck Cancer” Guest Editor: Dr. Joshua D. Smith Deadline for manuscript submissions: 31 October 2026
“Head and Neck Cancer: From Mechanisms to Therapeutic Approaches—Advances and Challenges” Guest Editors: Dr. Barbara Verro, Dr. Carmelo Saraniti and Dr. Daniela Carlisi Deadline for manuscript submissions: 31 October 2026	“Targeting Head and Neck Cancer: From Tumor Microenvironment to Therapy Resistance” Guest Editors: Prof. Dr. Ratna B. Ray and Dr. Subhayan Sur Deadline for manuscript submissions: 15 November 2026

Conference: The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026)
Organization: European Association for the Study of Diabetes
Date: 28 September–2 October 2026
Place: Allianz MiCo—Milan Convention Centre, Milan, Italy
Booth Number: L.03

The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy. This global diabetes conference will convene thousands of delegates from all across the globe to explore the latest advancements in diabetes research, treatment, and care.​

The scientific programme will feature hundreds of presentations, including keynote lectures, symposia, and oral sessions, offering insights into cutting-edge developments in both basic and clinical diabetes research. Attendees will have the opportunity to engage with leading experts, fostering collaboration and knowledge exchange across the international diabetes community.​

The Organization of this conference, the European Association for the Study of Diabetes e.V. (EASD), is a membership-based academic non-profit organization. It was founded in 1965 and is based in Düsseldorf, Germany. The aims of EASD are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application.

The following open access journals will be represented:

• Biomedicines;
• Diabetology;
• JCM;
• Medicina;
• Endocrines;
• IJERPH;
• Antioxidants;
• Biomolecules;
• Epidemiologia;
• JMAHP;
• Nutrients;
• Trends in Public Health.

If you are attending the 62nd EASD Annual Meeting, we invite you to visit us at our booth #L.03. Our representatives will be available to discuss publishing opportunities, the benefits of open access, and answer any questions that you may have.

Join us in Milan to discover what is next in diabetes science and care! For more information about the conference, please visit its official website at https://www.easd.org/annual-meeting/easd-2026/.

Glaucoma is a group of eye diseases that can cause damage to the optic nerve, leading to visual field defects and even vision loss; its high rate of blindness has become a critical challenge that urgently needs to be addressed in clinical ophthalmology and related medical research. The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal on clinical and pre-clinical research. We invite you to read the recent highly cited papers on glaucoma and explore related Special Issues focusing on hot topics in glaucoma research.

Furthermore, to discover more hot topics in our “Ophthalmology” Section, please visit here.

1. “Current Status and Future Perspectives of Optic Nerve Imaging in Glaucoma”
by Claudia Lommatzsch and Christian van Oterendorp
J. Clin. Med. 2024, 13(7), 1966; https://doi.org/10.3390/jcm13071966
Full text available online: https://www.mdpi.com/2077-0383/13/7/1966

2. “Optic Nerve Neuroprotection in Glaucoma: A Narrative Review”
by Angela D’Angelo, Livio Vitiello, Filippo Lixi, Giulia Abbinante, Alessia Coppola, Vincenzo Gagliardi, Alfonso Pellegrino and Giuseppe Giannaccare
J. Clin. Med. 2024, 13(8), 2214; https://doi.org/10.3390/jcm13082214
Full text available online: https://www.mdpi.com/2077-0383/13/8/2214

3. “Normal-Tension Glaucoma and Potential Clinical Links to Alzheimer’s Disease”
by Kathleen Ho, Nicole E. Bodi and Tasneem P. Sharma
J. Clin. Med. 2024, 13(7), 1948; https://doi.org/10.3390/jcm13071948
Full text available online: https://www.mdpi.com/2077-0383/13/7/1948

4. “Lights and Shadows on Artificial Intelligence in Glaucoma: Transforming Screening, Monitoring, and Prognosis”
by Alessio Martucci, Gabriele Gallo Afflitto, Giulio Pocobelli, Francesco Aiello, Raffaele Mancino and Carlo Nucci
J. Clin. Med. 2025, 14(7), 2139; https://doi.org/10.3390/jcm14072139
Full text available online: https://www.mdpi.com/2077-0383/14/7/2139

5. “Paul Glaucoma Implant following Congenital Cataract Surgery in a Pediatric Cohort”
by Angi Lizbeth Mendoza-Moreira, Anna Maria Voigt, Julia V. Stingl, Jasmin Rezapour, Felix Mathias Wagner, Alexander K. Schuster and Esther M. Hoffmann
J. Clin. Med. 2024, 13(10), 2914; https://doi.org/10.3390/jcm13102914
Full text available online: https://www.mdpi.com/2077-0383/13/10/2914

6. “Diagnostic Capability of OCTA-Derived Macular Biomarkers for Early to Moderate Primary Open Angle Glaucoma”
by Alice Verticchio Vercellin, Alon Harris, Francesco Oddone, Carmela Carnevale, Brent A. Siesky, Julia Arciero, Brendan Fry, George Eckert, Paul A. Sidoti, Gal Antman et al.
J. Clin. Med. 2024, 13(14), 4190; https://doi.org/10.3390/jcm13144190
Full text available online: https://www.mdpi.com/2077-0383/13/14/4190

7. “Is the Advent of New Surgical Procedures Changing the Baseline Features of Patients Undergoing First-Time Glaucoma Surgery?”
by Alessandro Palma, Giuseppe Covello, Chiara Posarelli, Maria Novella Maglionico, Luca Agnifili and Michele Figus
J. Clin. Med. 2024, 13(11), 3342; https://doi.org/10.3390/jcm13113342
Full text available online: https://www.mdpi.com/2077-0383/13/11/3342

8. ‘Randomized, Cross over, Multicenter, Single-Blind Study Comparing Citicoline 500 mg/Homotaurine 50 mg/Vitamin B3 54 mg/Pyrroloquinoline Quinone 5 mg (Neuprozin Mito^®) and Citicoline 800 mg (Cebrolux^®) on Pattern Electroretinogram (PERG) and Quality of Life in Patients with Primary Open-Angle Glaucoma with Well-Controlled Intraocular Pressure”
by Gemma Caterina Maria Rossi, Michele Rinaldi, Francesco Matarazzo, Diego Strianese, Giuseppe Campagna, Michele La Ragione, Paolo Esposito Veneruso, Giovanni Scapagnini and Ciro Costagliola
J. Clin. Med. 2025, 14(11), 3774; https://doi.org/10.3390/jcm14113774
Full text available online: https://www.mdpi.com/2077-0383/14/11/3774

9. “Clinical Practice Preferences for Glaucoma Surgery in Japan in 2024”
by Kentaro Iwasaki, Shogo Arimura, Yoshihiro Takamura and Masaru Inatani
J. Clin. Med. 2025, 14(6), 2039; https://doi.org/10.3390/jcm14062039
Full text available online: https://www.mdpi.com/2077-0383/14/6/2039

10. “Next-Gen Neuroprotection in Glaucoma: Synergistic Molecules for Targeted Therapy”
by Alessio Martucci, Massimo Cesareo, Maria Dolores Pinazo-Durán, Francesco Aiello, Giulio Pocobelli, Raffaele Mancino and Carlo Nucci
J. Clin. Med. 2025, 14(17), 6145; https://doi.org/10.3390/jcm14176145
Full text available online: https://www.mdpi.com/2077-0383/14/17/6145

Conference: 60th Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
Date: 3–5 June 2026
Location: Lisbon, Portugal

MDPI will participate as an exhibitor at the 60th Annual Scientific Meeting of the European Society for Clinical Investigation. We welcome researchers and professionals to visit our booth and engage with our team.

The 60th Annual Scientific Meeting (ASM) of the European Society for Clinical Investigation (ESCI) will be held from 3 to 5 June 2026. It can bring together 500–600 scientists, medical professionals, and innovation leaders from across Europe and beyond to explore the theme “Research in Action: Building Healthier Futures”. The scientific program will feature a rich blend of disciplines—spanning cardiovascular science, endocrinology, obesity, metabolism and MASLD, mitochondrial biology, oncology and immunology, rheumatology, and neurosciences. This year, we will shine a spotlight on life transitions in women, unravelling health and disease journeys from pregnancy to menopause. The program will also highlight today’s most transformative biomedical breakthroughs, from AI-enabled diagnostics to gene editing and precision therapies.

The following open access journals will be represented:

• Reports;
• Medicina;
• Diagnostics;
• JPM;
• BioMed;
• Complications;
• Pharmacy;
• NeuroSci;
• JCRM;
• Current Oncology;
• JCM;
• Physiologia;
• Proteomes;
• Diseases.

If you are planning to attend the above event, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information, please visit https://barcelo.eventsair.com/QuickEventWebsitePortal/esci-2026/web.